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Abstract
Background: Human metapneumovirus (HMPV) is an important cause of acute respiratory illness in young children.
Whole genome sequencing enables better identification of transmission events and outbreaks, which is not always
possible with sub-genomic sequences.
Results: We report a 2-reaction amplicon-based next generation sequencing method to determine the complete
genome sequences of five HMPV strains, representing three subgroups (A2, B1 and B2), directly from clinical samples.
In addition to reporting five novel HMPV genomes from Africa we examined genetic diversity and sequence patterns
of publicly available HMPV genomes. We found that the overall nucleotide sequence identity was 71.3 and 80% for
HMPV group A and B, respectively, the diversity between HMPV groups was greater at amino acid level for SH and G
surface protein genes, and multiple subgroups co-circulated in various countries. Comparison of sequences between
HMPV groups revealed variability in G protein length (219 to 241 amino acids) due to changes in the stop codon
position. Genome-wide phylogenetic analysis showed congruence with the individual gene sequence sets except for F
and M2 genes.
Conclusion: This is the first genomic characterization of HMPV genomes from African patients.
Keywords: Metapneumovirus, Genome, Diversity
Background
Human metapneumovirus (HMPV) is a single-stranded
RNA virus in the family Paramyxoviridae and closely re-
lated to human respiratory syncytial virus (RSV) [1].
HMPV causes respiratory disease similar to RSV, ranging
from mild upper respiratory infection to bronchiolitis and
pneumonia [2]. HMPV infections are seasonal and co-
infection with other respiratory pathogens is common [1].
The HMPV genome is approximately 13 kb and comprises
eight open reading frames (ORFs) encoding nucleoprotein
(N), phosphoprotein (P), matrix protein (M), fusion glyco-
protein (F), transcription enhancer protein (M2), small
hydrophobic protein (SH), attachment glycoprotein (G),
and large polymerase protein (L) [3]. The membrane gly-
coproteins F and G sequences are used to define two
major genotypes or groups, A and B, which are further
classified into four subgroups (A1, A2, B1, and B2).
HMPV A2, the most frequently observed subgroup, is fur-
ther divided into two proposed sub-lineages (A2a and
A2b) [3].
HMPV is reported to have an important contribution
to acute respiratory infections (ARI) in Africa. For in-
stance, HMPV-associated hospitalization was estimated
at 6.5 per 1000 person years in infants in Soweto, South
Africa [4]; at 4% in hospitalized children with severe ARI
during a 2-year period in Cameroon [5]; and in rural
western Kenya, incidence of HMPV associated with ARI
cases in outpatient clinic visits was estimated at 0.43 per
100 person-years among outpatients [6]. In Kilifi coastal
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Kenya, between January 2007 to December 2011, chil-
dren under 6months of age accounted for 44% of
HMPV positive cases, while 74% were children under 1
year, and 1.3% (2/160) were children > 36 months [7]. In
Dadaab and Kakuma refugee camps in Kenya, HMPV
was detected in 5.7% hospitalizations, and virus-positive
crude hospitalization rate (per 1000 children < 5 years
old) was 4 for HMPV [8]. In Mali, contribution of
HMPV to pneumonia had a population attributable frac-
tion of 9% (95% CI: 7–11%) [9]; while in Morocco [10],
8.9% of children < 5 years admitted with severe pneumo-
nia were infected with HMPV. HMPV prevalence and
incidence elsewhere globally, is indicated in Add-
itional file 4: Table S1. Of note is that the variations in
incidence rates could be attributed to study population,
seasonality and even detection methods. Nonetheless,
genomic epidemiology of HMPV in Africa is inad-
equately reported, and comparison of genetic similarity
and differences between African and global strains is not
documented.
Genome sequences provide valuable resources for charac-
terizing viral evolution and disease epidemiology, and for
identifying transmission events and outbreaks, which is not
always possible with sub-genomic fragments [11–13]. The
increased number of phylogenetically informative variant
sites obtained from full genomes may allow better linking of
cases and aid public health interventions in real time during
epidemics [14, 15]. PCR approaches for targeted whole gen-
ome sequencing, in contrast to random amplification, can
preferentially amplify the target virus over host or environ-
mental nucleic acids [16, 17] potentially focusing sequencing
on the virus of interest. To date, the largest dataset of HMPV
whole genomes (n = 61) sequenced from any tropical coun-
try is from three Peruvian cities, Lima, Piura and Iquitos [18].
In Africa, apart from one metapneumovirus genome identi-
fied from a wild mountain gorilla in Rwanda (GenBank
accession number HM197719), there are no HMPV ge-
nomes reported according to the NIAID Virus Pathogen
Database and Analysis Resource (ViPR, http://www.viprbrc.
org/, accessed April 30, 2019). This has led to limited
understanding of the genetic and genomic diversity of
HMPV in the continent.
This work describes a whole genome sequencing
(WGS) approach for HMPV from a small number of
HMPV positive clinical samples collected at Kilifi
County Hospital in Kilifi, Kenya and University Teaching
Hospital in Lusaka, Zambia. The genomes were gener-
ated by sequencing overlapping PCR amplicons spanning
the entire genome. These are the first reported complete
genome sequences of locally circulating HMPV strains
obtained directly from clinical samples in Africa. We
also combined the new genomes with publicly available
sequences to examine patterns in global HMPV genetic
diversity.
Results
Genome characteristics
Whole genome sequencing was successful for all 5 clin-
ical samples that were attempted. A single genomic se-
quence was obtained from each sample, and the length
of the 5 new HMPV genomes ranged from 13,097 to 13,
134 nt (> 95% length coverage). Sequencing and data as-
sembly parameters, including coverage depth are shown
in Table 1.
Sequence annotation of the full-length genomes using
Geneious R8.1.5 (https://www.geneious.com) identified
the expected eight coding ORFs and non-coding gen-
omic regions. The overall nucleotide identity (i.e., identi-
cal sites averaging over all sequence pairs and excluding
positions containing gaps) between all 143 genome se-
quences analyzed (5 new genomes plus 138 from ViPR)
was 58.2%. Nucleotide sequence identity was 71.3%
within HMPV-A and 80% within HMPV-B. Intra-
subgroup, A1, A2, B1 and B2 genomes shared 92.1% (10
sequences), 76.8% (88 sequences), 91% (24 sequences)
and 89.6% (21 sequences) amino acid sequence identity.
For the 143 HMPV genomes, we checked sequence
conservation at transcriptional control regions, at the
termini of each gene, as well as the lengths of intergenic
sequences between gene boundaries. The length of the
Table 1 Sequencing results and data assembly metrics for the five HMPV genomes. Data assembly parameters are provided in the
table footnotes
Strain Total reads HMPV readsa N50b Genome length Ctc Mean coveraged GenBank accession Sub-groupe
HMPV/01/KEN/2015 916,378 42% 12,561 13,101 27.4 14,430.68 MK588634 A2b
HMPV/02/KEN/2012 653,642 38% 13,032 13,104 26.0 4856.963 MK588637 B2
HMPV/03/KEN/2013 684,104 39% 12,962 13,134 21.0 7207.968 MK588633 A2b
HMPV/04/KEN/2012 766,948 22% 12,489 13,097 22 6764.68 MK588636 B1
HMPV/05/ZAM/2012 962,668 26% 13,011 13,145 27.2 10,444.95 MK588635 A2a
aPercentage of sequencing reads classified as HMPV
bN50 length (a measure of genome assembly completeness) is calculated by summing lengths of assembled contigs from the longest to the shortest and
determining the point at which 50% of the total assembly size is reached.
crRT-PCR cycle threshold value.
dCalculated by dividing the per-position coverage output (described in Methods) by respective genome length
eAs assigned by phylogenetic analyses.
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F-M2 intergenic region was different between group A
and B viruses, that is, 13 nt and 2 nt, respectively. The
SH-G and G-L intergenic regions were the longest, up
to 125 nt and to 190 nt, respectively. Consensus nucleo-
tides (9 to 19 length) at the putative start and end
regions flanking the ORF of the viral genes are shown in
Fig. 1.
The gene-start and -end regions of N and P were con-
served (> 90% average pairwise identity) in both HMPV
groups, and the M2 and M gene-start and -end were also
conserved in HMPV group A and B, respectively. The pu-
tative ATG start codon was consistently located at posi-
tions 14–16 upstream of a gene start motif (consensus:
GG/AGAC/TAAA/GTnnnnATG), except for the internal
M2–2. An additional ATG start codon upstream of the
gene-start motif was observed in the SH gene for the B1
and B2 strains. In five of the eight annotated genes (N, P,
F, M2, and G (B1 and B2 strains only)), the intergenic re-
gions were short and the ORFs for these 5 genes termi-
nated within the propositioned gene-end motifs.
Sequence diversity and phylogenetic relationships
We combined the five genome sequences from Kenya
and Zambia with available global sequences, aligned
individual genes and calculated the percent nucleotide
(nt) and amino acid (aa) identity (Table 2).
The coding sequences of N, M, F, M2–1, M2–2, and L
genes were conserved at nucleotide and amino acid
levels, by sharing > 85% between-subgroup nucleotide
identity and 90% protein identity (Table 3). The nucleo-
protein gene was the most conserved among all sub-
groups at the nt and aa levels. SH and G glycoprotein
genes were more divergent between the HMPV sub-
groups at the nucleotide level with 76 and 63% identity,
respectively. The SH protein length was variable between
group A and B strains due to a nucleotide substitution
(CAA ➔ TAA) at gene position 532 in group B, result-
ing in protein lengths of 178 and 180 aa, respectively.
The predicted G protein length also varied among the
different HMPV subgroups, between 219 and 241 aa,
due to different positions of the Stop codon. Amino acid
sequence diversity for G and SH glycoproteins is
depicted in Fig. 2 and Additional file 2: Figure S2,
respectively. The diversity of the complete nucleotide se-
quences of SH and G genes is depicted in phylogenetic
trees in Fig. 3.
We evaluated phylogenetic classification and relation-
ship between the 5 new genomes obtained in this study
and previously published genomes (Fig. 3). Full genome
Fig. 1 Consensus nucleotide sequences of putative gene-start (13 nucleotides upstream of ATG codon) and gene-end signals (6–16 nucleotides
from Stop codon) visualized as sequence logos, for HMPV group (a) and (b). The height of each character in the sequence logo plots is proportional to
its relative frequency. The green color on the bar at the bottom of the consensus sequence logo indicates 100% average pairwise identity, brown
indicates at least 30 to < 100% identity and red indicates < 30% identity
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classification was consistent with that based on partial
genomic fragments (F and G genes). Two genomes from
the samples collected in Kenya (HMPV/03/KEN/2013)
and (HMPV/01/KEN/2015), clustered closely to viruses
from USA (collected in 2016/17) and Thailand (collected
in 2013) within the A2 subgroup (Fig. 3). The A2a virus
sequenced from Zambia (HMPV/05/ZAM/2012) clustered
closely with Peruvian HMPV strains collected in 2012,
with > 89% nt similarity, and the B2 genome from Kenya
(strain HMPV/02/KEN/2012) shared more than 90% nt
similarity with a virus collected in the U.S. in 2015. The
B1 genome from Kenya (strain HMPV/04/KEN/2012) ex-
hibited 97.5% nucleotide similarity with viruses collected
in 2004 in Australia and USA. The diversity of the
complete nucleotide sequences of N, P, M, F, M2 and L
genes is depicted in phylogenetic trees in Additional file 3:
Figure S3. There was phylogenetic congruence with the
individual gene sequence sets as with the full genome
dataset, except for F and M2 gene (Additional file 3:
Figure S3).
Sequence diversity at rRT-PCR target region
Variant or drifted viral strains may lower the sensitivity of
detection resulting in a decreased quantitation of the viral
load and underestimation of disease incidence [19]. We
checked the new HMPV genomes for nucleotide differ-
ences in the genomic regions targeted by our diagnostic
rRT-PCR primers and probes (Additional file 7: Table S4)
used for HMPV detection. Up to eight primer- and probe-
template mismatches were identified (Fig. 4): one mis-
match in the forward primer region in HMPV group A (F
gene-based rRT-PCR assay, Fig. 4a); one mismatch in each
of the forward and probe target regions in group B (F
gene-based rRT-PCR assay, Fig. 4b); and 5 different mis-
matches with the N-gene based rRT-PCR assay (Fig. 4c).
Note, the F gene-based rRT-PCR assays are different or
specific to the two HMPV groups.
Discussion
HMPV causes respiratory illness presenting as mild
upper respiratory tract infection or life-threatening se-
vere bronchiolitis and pneumonia primarily in children,
sometimes adults as well as immunocompromised indi-
viduals [2]. However, HMPV genome sequence data
from Africa is sparse and information on genome-wide
diversity is limited. In the present study, the whole gen-
ome sequences of five HMPV strains from Kenya and
Zambia were determined and compared with the ge-
nomes published previously from around the world.
Comparative sequence analysis indicated fairly conserved
positioning of the gene-start and -end regions as well as
translational start and -end codons. Variation in gene-
start and -end sequences can have significant impact on
transcription initiation and termination efficiency so that
there is more selective pressure preventing changes in
these regions [20], and this likely explains our observa-
tion. The additional ATG start codon found upstream of
the gene-start motif of the SH gene was consistent with
a previous report [21], though its role in gene expression
is yet to be identified.
These observed sequence conservation in N, M, F,
M2–1, M2–2, and L genes is not unusual and is suggest-
ive of functional and structural constraints on diversity,
but less expected of the F gene because of its status as a
neutralization and protective antigen, similar to its close
‘relative’ RSV [22]. It has also been suggested that the
low diversity in F gene might make a substantial contri-
bution to cross-neutralization and cross-protection be-
tween the HMPV subgroups [21]. The relatively high
frequency of amino acid diversity in G (and to a lesser
extent SH) could be attributable to selective pressure for
Table 2 Levels of nucleotide and amino acid identitya of sequences
within the two major HMPV groups. This analysis included the new
sequences from Kenya and Zambia plus the global sequences
retrieved from GenBank
Average % nucleotide identity Average % amino acid identity
Group A Group B Group A Group B
N 90.3 91.3 97.6 98.4
P 86.6 87.4 90.0 91.1
M 90.1 90.7 97.8 98.5
F 88.6 88.9 94.8 96.0
M2 89.0 89.9 94.2 95.7
SH 75.8 76.5 72.5 73.8
G 63.0 66.9 50.1 57.8
L 89.8 90.3 96.5 97.6
aCalculated as mean pairwise identity over all pairs in a column or position.
Table 3 Demographic and clinical information collected from patients at the point of sampling
Strain ID Sample collection date Gender Age Clinical manifestation
HMPV/01/KEN/2015 23/12/2015 Male 5 months Fever, cough, difficulty breathing, severe pneumonia
HMPV/02/KEN/2012 15/04/2012 Female 7 months Fever, cough, chest indrawing, severe pneumonia
HMPV/03/KEN/2013 30/10/2012 Male 2 months Cough, breathing difficulty, chest indrawing, crackles, severe pneumonia
HMPV/04/KEN/2012 06/01/2012 Male 4 years Fever, breathing difficulty, vomiting, severe pneumonia
HMPV/05/ZAM/2012 28/02/2012 Female 7 months Fever, cough, difficulty breathing, severe pneumonia
Kamau et al. BMC Genomics            (2020) 21:5 Page 4 of 10
amino acid change coming from host immunity; and the
ability of the protein to tolerate substitutions, which
might be due to its proposed extended, unfolded nature
[22]. The phylogenetic incongruence observed between
whole genome tree and the F and G gene trees, is as re-
ported previously for HMPV [23], and could be attrib-
uted to differential rates of evolution, selection pressure
or past recombination events [24].
The prevalence of HMPV in hospitalized pediatric
population in Kilifi county in coastal Kenya has been re-
ported [7, 25]. However, it is notable that in recent years,
HMPV has been detected at low prevalence in Kilifi (un-
published observations from hospital-based pneumonia
surveillance). Whether this low prevalence is due to re-
duced virus transmission, or decreased sensitivity of our
HMPV molecular diagnostic assay due to progressive
primer/probe mismatches, is yet to be established.
Conclusion
We present the first full genome sequences of circulating
HMPV strains from sub-Saharan Africa. A limitation of
our sequencing method, as is common with amplicon
sequencing protocols [26, 27], was absent coverage at
the 3′ leader and 5′ trailer regions not captured by these
primers. Our results demonstrate the application of
amplicon sequencing to generate full length HMPV ge-
nomes directly from clinical samples. The observed di-
versity of the individual genes is comparable to that
described previously [20–22]. This method and data pro-
vide a useful reference for design of local molecular
diagnostics and for studies aimed at understanding
HMPV epidemiology and evolution in Africa.
Methods
HMPV detection and genotype assignment
Nasopharyngeal and oropharyngeal (NP-OP) swab sam-
ples were collected from children (1–59months) hospi-
talized with pneumonia, four of whom were enrolled in
the PERCH study [18] in 2012. The fifth sample was col-
lected from a child enrolled in the routine pneumonia
surveillance study at Kilifi County Hospital, Kenya, in
2015. The samples were tested for HMPV by multiplex
semi-quantitative real-time reverse transcription PCR
(rRT-PCR) assays. The rRT-PCR primers and probes
used, cycling conditions and assay set up have been de-
scribed elsewhere [28, 29]. Fusion (F) and glycoprotein
Fig. 2 Average pairwise identity over all pairs in an alignment for every position of the predicted G glycoprotein amino acid sequences, for HMPV
groups (a) and (b). The dataset analyzed here included all available genomes (Kenya and Zambia (n = 5) plus 138 from other locations globally).
The average pairwise identities were calculated in Geneious R8.1.5. Black bars indicate > 50% (> 0.5) average amino acid identity and red bars
indicate < 50% (< 0.5) non-identity among sequences. Proposed intracellular (positions 1 to 32), transmembrane (TM, positions 33 to 51), and
extracellular (positions 52 to 220 for group (a), 52 to 242 for group (b) domains are indicated above the plots
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(G) encoding genes of the HMPV positive samples were
amplified in a one-step RT-PCR assay (OneStep RT-
PCR kit, QIAGEN), as described previously [7]. Partial G
or F nucleotide sequences were analyzed by maximum
likelihood (ML) phylogenetic trees using IQ-TREE [30],
together with reference strains of HMPV subgroups (ac-
cession numbers AF371337.2, FJ168779, AY297749,
AY530095, JN184401 and AY297748). Five HMPV posi-
tive samples from the Kenya and Zambia study sites, be-
longing to the A2a (n = 1), A2b (n = 2), B1 (n = 1) and B2
(n = 1) genetic subgroups based on their G and F gene
sequences, were selected for whole genome sequencing.
Data on age, sex and clinical assessment information
collected at the time of sample collection, for the five se-
lected samples, are shown in Table 3.
Whole genome sequencing
The sequencing protocol consisted of four steps as follows:
(i) primer design, (ii) preparation of primer mixes, (iii) cDNA
and PCR (iv) Illumina sequencing and data analysis.
Preparation of HMPV Tm48 full genome primers
All human metapneumovirus (HMPV) full genome se-
quences were retrieved from GenBank (January 2018) using
the query (txid162145 (Organism) AND 12000(SLEN):
14000(SLEN) NOT patent). Sequence entries with gaps lar-
ger than 6 nt were excluded to generate a set of yielding 178
genomes. All possible 23 nt sequences were generated from
the genomes dataset and trimmed to a final calculated melt-
ing temperature (Tm) of 47.9–49.5 °C. Sequences with
homology to rRNA sequences, with GC content outside <
0.3 or > 0.75 or with a single nucleotide fractional content of
> 0.6 were discarded. The primer set was then made non-
redundant yielding 60,746 potential primers. All potential
primers were mapped against the 178 HMPV full genomes
and the number of perfect matches (frequency score) was de-
termined as a measure of primer sequence conservation. To
select primers, the HMPV genome sequences were divided
into amplicons with 222 nt overlap spanning the virus gen-
ome. Potential primers that mapped within the terminal 5′
and 3′ 222 nt of each amplicon were identified and the se-
quence with the highest frequency score was selected, and
primers mapping to the reverse bins were reverse comple-
mented. In this manner, 24 primers were selected for each of
the 4 HMPV genotype representative genomes (GenBank
accession number HMPV A1: AF371337, HMPV A2:
FJ168779; HMPV B1: AY525843, and HMPV B2: FJ168778).
Because of conservation between genotypes, there was
primer redundancy which was removed. The final set of 65
primer sequences, their lengths, calculated Tm, fractional
GC content and mapping position on the HMPV genome
are presented in Additional file 5: Table S2. The primers
were computationally tested against each of the 4 HMPV
subgroups. A graphical representation of the primer target
sites is presented in Additional file 1: Figure S1.
Preparation of primer mixes
Amplification was performed in two reactions. To avoid
generating small products from adjacent forward and
reverse primers, amplicons were assigned to alternate
Fig. 3 Mid-pointed maximum-likelihood (ML) phylogenetic trees of SH glycoprotein gene (a) G glycoprotein gene (b) and the full-length genome
sequences (c) of viruses from Kenya and Zambia (marked in red), plus 138 other sequences (> 13 kb) retrieved from GenBank (Additional Table 3).
Bootstrap support values (evaluated by 1000 replicates) are indicated along the branches. Genetic subgroups A1, A2a, A2b, B1, and B2, are indicated.
Multiple sequence alignment was done using MAFFT and the ML phylogeny inferred using GTR + Γ nucleotide substitution model and ultrafast
bootstrap approximation in IQ-TREE. The genotype B2 Sabana strain sequence (GenBank accession number HM197719) reported from a wild mountain gorilla
in Rwanda is marked in blue. The scaled bar indicates nucleotide substitutions per site
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reactions, with reaction 1 containing primers for ampli-
cons 1,3,5,7,9,11; reaction 2 containing primers for
amplicons 2,4,6,8,10,12. Each reverse transcription used
Forward Primer Mixes (FPMs) made with 3.0 μl of each
reverse primer (100 pmol/μl) plus water to 200 μl to
generate a primer concentration of 24 pmol/μl. Two
microlitre of the FPM is then used in a 20 μl reverse
transcription reaction (2.4 pmol/μl final concentration in
reaction or 2.4 μM/primer). For PCR amplification, each
amplicon reaction used a separate PCR Primer Mix
(PPM) containing 1.5 μl of each 100 pmol/μl forward pri-
mer and 1.5 μl of each reverse primer (5.3–5.5 pmol/μl
total primer in the PPM). 2 μl PPM was used per 25 μl
PCR reaction = 0.5 pmol/μl in reaction (= 500 nM).
cDNA synthesis and PCR
Viral nucleic acids were extracted from the original samples
using QIAamp Viral RNA Mini kit (QIAGEN). RNA (5 μl)
was reverse transcribed into cDNA using SuperScript III
(200U, Invitrogen), RT buffer (1X final concentration, Invi-
trogen), and 2 μl of FPM in 20 μl reactions. An aliquot of
cDNA (5 μl) was amplified in 35 cycles using Phusion High-
fidelity PCR kit (New England Biolabs) and 2 μl of PPM in a
25 μl reaction. The PCR mixture was incubated at 98 °C for
30 s, followed by 35 cycles of 98 °C for 10 s, 43 °C for 30 s,
and 72 °C for 90s and a final extension of 72 °C for 10min.
Expected PCR products for each amplicon were approxi-
mately 1500 bp. PCR products from the two reactions for
each sample were pooled for Illumina library preparation.
Fig. 4 Mismatches between the rRT-PCR diagnostic primers and probes and their expected binding sites in the five genomes from Kenya and
Zambia. ‘Fwd primer’ = Forward primer and ‘Rev primer’ = Reverse primer. Two rRT-PCR assays were used for HMPV detection. The colored bars in
the figure indicate nucleotide differences (mismatches) between (a) three HMPV-A genomes and HMPV-A specific primers and probes targeting
fusion gene, (b) two HMPV-B genomes and HMPV-B specific primers and probes also targeting fusion gene, and (c) all five genomes reported
here and specific primers and probes targeting nucleoprotein gene. The sequences of the rRT-PCR primers and probes checked against the
African HMPV genomes are listed in Additional file 7: Table S4
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Illumina sequencing and data analysis
Libraries were prepared using Nextera XT kit (Illumina)
and pair-end sequencing (2 × 300 base pairs) with the
MiSeq Reagent V3 kit (Illumina), following the manufac-
turer’s instructions. The Nextera enzyme mix was used
to simultaneously fragment input DNA and tag with
universal adapters in a single tube reaction, followed by
12-cycle PCR reaction for dual indexing. Agencourt
AMPure XP beads (Beckman Coulter) were used for all
purification steps and libraries were quantified and
quality-checked using the Qubit (Thermo Fisher) and
Bioanalyzer (Agilent). Adapter trimming, quality filter-
ing, kmer normalization of sequencing reads, de novo
assembly, calculation of mean genome coverage was as
previously described [31].
Phylogenetic analyses
A dataset of HMPV genome sequences was retrieved from
ViPR in order to infer relationship between HMPV viruses
from Kenya and Zambia and viral populations sampled glo-
bally. The dataset included 138 sequence entries (> 13,000
nt) that included date (year) and location of sample
Fig. 5 Flow chart diagram depicting a summary of methods applied in this study
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collection (Additional file 6: Table S3). Sequence alignment
was done using MAFFT v.7.221 [32] using the parameters ‘–
localpair –maxiterate 1000’. IQ-TREE was used to infer max-
imum likelihood (ML) trees of the complete genome and
individual genes under general time-reversible (GTR) substi-
tution model with gamma-distributed among-site rate het-
erogeneity. A summary of the methodology outlined here is
depicted in Fig. 5.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12864-019-6400-z.
Additional file 1: Figure S1. The target positions in HMPV genomes for
the set of 65 HMPV primers are presented. Green diamonds indicate
forward primers, blue diamonds indicate reverse primers. Primers sites in
representative A1, A2, B1 and B2 genomes are shown (HMPV A1:
GenBank accession number AF371337, HMPV A2: FJ168779; HMPV B1:
AY525843 and HMPV B2: FJ168778).
Additional file 2: Figure S2. Average pairwise identity over all pairs in
an alignment for every position of the predicted SH glycoprotein amino
acid sequences, for HMPV groups A (A) and B (B). The dataset analyzed
here included all available genomes (Kenya and Zambia (n = 5) plus 138
from other locations globally). Black bars indicate > 50% (> 0.5) average
amino acid identity and red bars indicate < 50% (< 0.5) non-identity
among sequences. Proposed intracellular (positions 1 to 30), transmem-
brane (TM, positions 31 to 51), and extracellular (positions 52 to 178 for
group A, or 52 to 180 group B) domains are indicated above the plots.
Additional file 3: Figure S3. Mid-pointed maximum-likelihood (ML)
phylogenetic trees of N gene (A), P gene (B), M gene (C), M2 gene (D), F
gene (E), and L gene (F) of viruses from Kenya and Zambia (marked in
red), plus 138 other genomes (> 13 kb) retrieved from GenBank. Bootstrap
supports (evaluated by 1000 replicates) are indicated at the nodes. Gen-
etic subgroups and lineages, A1, A2a, A2b, B1, and B2, are indicated. Mul-
tiple sequence alignment was done using MAFFT v7.221 and the ML
phylogeny inferred using GTR + Γ nucleotide substitution model and ul-
trafast bootstrap approximation in IQ-TREE. The genotype B2 Sabana
strain sequence (GenBank accession number HM197719) reported from a
wild mountain gorilla in Rwanda is marked in blue.
Additional file 4: Table S1. Summaries of HMPV prevalence and
incidence as reported in various publications.
Additional file 5: Table S2. Primer sequences used in RT-PCR for whole
genome amplification. Primer nomenclature is described as follows: AF-
11A1 indicates an A reaction, forward primer for amplicon 11, selected
for genotype A1 (although it may function against the other 4 geno-
types). Also listed are the primer sequence (5′ to 3′) the primer length,
the melting temperature (calculated using the Santa Lucia algorithm
(https://biopython.org/DIST/docs/api/Bio.SeqUtils.MeltingTemp-module.
html) plus 3.7 C) to obtain the Breslauer values [33]) and the fraction of
the primer that is G + C [34].
Additional file 6: Table S3. Information (GenBank accession, year and
country of sample location) of the global sequences used in
phylogenetic analyses. (CSV 2 kb)
Additional file 7: Table S4. Primer sequences used in the semi-
quantitative rRT-PCR for HMPV detection. Note, the F gene-based rRT-PCR
assays are different or separate for the two HMPV groups.
Abbreviations
aa: Amino acid; ARI: Acute respiratory infections; cDNA: Complementary
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